Skip to content
10-K/A

Annual Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-22-002058

← back to feed
Filed
Sep 19, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Sep 19, 2022 160.79M sh
Shares Diluted FY 2021 · Dec 31, 2021 160.79M sh
Shares Diluted FY 2021 · Dec 21, 2020 160.79M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −$235.31K
Operating Cash Flow FY 2021 · Dec 31, 2020 −$85.61K
Cash And Equivalents FY 2021 · Dec 31, 2021 $6.51K
Cash And Equivalents FY 2021 · Dec 31, 2020 $26.73K
Cash And Equivalents FY 2021 · Dec 31, 2019 $61.75K
Stockholders Equity FY 2021 · Dec 31, 2021 −$7.92M
Stockholders Equity FY 2021 · Dec 31, 2020 −$7.41M
Stockholders Equity FY 2021 · Dec 31, 2019 −$6.91M
Current Liabilities FY 2021 · Dec 31, 2021 $10.84M
Current Liabilities FY 2021 · Dec 31, 2020 $10.45M
Total Liabilities FY 2021 · Dec 31, 2021 $10.84M
Total Liabilities FY 2021 · Dec 31, 2020 $10.45M
Current Assets FY 2021 · Dec 31, 2021 $29.78K
Current Assets FY 2021 · Dec 31, 2020 $50.92K
Total Assets FY 2021 · Dec 31, 2021 $2.92M
Total Assets FY 2021 · Dec 31, 2020 $3.04M
Net Income FY 2021 · Dec 31, 2021 −$499.78K
Net Income FY 2021 · Dec 31, 2020 −$396.03K
Operating Income FY 2021 · Dec 31, 2021 $521.28K
Operating Income restated FY 2021 · Dec 31, 2020 $524.75K
Gross Profit FY 2021 · Dec 31, 2021 $70.93K
Gross Profit FY 2021 · Dec 31, 2020 −$6.57K
Cost Of Revenue FY 2021 · Dec 31, 2021 $74.17K
Cost Of Revenue FY 2021 · Dec 31, 2020 $93.22K
Revenue FY 2021 · Dec 31, 2021 $145.1K
Revenue FY 2021 · Dec 31, 2020 $86.65K